國立虎尾科技大學 |

Psychopharmacology reconsidered = a concise guide exploring the limits of diagnosis and treatment /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Psychopharmacology reconsidered/ by Robert Haim Belmaker, Pesach Lichtenberg.
Reminder of title:	a concise guide exploring the limits of diagnosis and treatment /
Author:	Belmaker, Robert Haim.
other author:	Lichtenberg, Pesach.
Published:	Cham :Springer International Publishing : : 2023.,
Description:	xiv, 220 p. :ill., digital ; : 24 cm.;
Contained By:	Springer Nature eBook
Subject:	Psychopharmacology. -
Online resource:	https://doi.org/10.1007/978-3-031-40371-2
ISBN:	9783031403712

Psychopharmacology reconsidered = a concise guide exploring the limits of diagnosis and treatment /
Belmaker, Robert Haim.

Psychopharmacology reconsidereda concise guide exploring the limits of diagnosis and treatment /[electronic resource] :by Robert Haim Belmaker, Pesach Lichtenberg. - Cham :Springer International Publishing :2023. - xiv, 220 p. :ill., digital ;24 cm.

This thought-provoking book covers the full range of psychopharmacologic practice in textbook fashion, offering a fresh and comprehensive self-examination. Unlike conventional texts of psychopharmacology, this text speaks directly to clinicians who have started to question the limitations of psychopharmacologic claims and the rigid confines of DSM-5 diagnoses. Drawing from their clinical and research experience as well as new literature, the well-published authors provide a new perspective that encourages readers to reevaluate established practices and embrace that medication is just one component of treatment and has limits. The book could be used by psychiatric residents in their course of study, by clinical psychology students taking a psychopharmacology course, or by psychiatrists curious to get a readable but comprehensive look at new critical viewpoints in psychopharmacology that have changed since they were taught. Many neuroscience students who are looking for a review of clinical effects to guide their basic research may also find the proposed text more useful than those texts that collate clinical trials. Current texts are for specialized scientists or are part of multi-authored texts which list drugs alphabetically with no conceptual framework, or books that pretend that each biochemical drug property has a clear and known clinical result presented in cartoon style. Some lesser known texts for psychology or nursing students are not authoritative. Others aimed at patients or families are too simplistic for clinicians. The authors' goal was to create a unified text expressing their view of psychopharmacology, its evidence base, the unity of its essential principles, and its independence of DSM or ICD diagnosis. Several new history books describe the "rise and fall" of psychopharmacology, the corruption of big pharma and the failure of large controlled clinical trials. Psychopharmacology Reconsidered: A Concise Guide Exploring the Limits of Diagnosis and Treatment ensures that young clinicians are aware of and understand this critical zeitgeist but aware also of the essential core of psychopharmacology and the evidence upon which it rests.

ISBN: 9783031403712

Standard No.: 10.1007/978-3-031-40371-2doiSubjects--Topical Terms:

644799
Psychopharmacology.

LC Class. No.: RM315 / .B45 2023

Dewey Class. No.: 615.78

Psychopharmacology reconsidered = a concise guide exploring the limits of diagnosis and treatment /
LDR:03199nam a2200313 a 4500 001 1117884
003 DE-He213
005 20231018083303.0
006 m d
007 cr nn 008maaau
008 240126s2023 sz s 0 eng d
020 $a 9783031403712 $q (electronic bk.)
020 $a 9783031403705 $q (paper)
024 7 $a 10.1007/978-3-031-40371-2 $2 doi
035 $a 978-3-031-40371-2
040 $a GP $c GP
041 0 $a eng
050 4 $a RM315 $b .B45 2023
072 7 $a MMH $2 bicssc
072 7 $a MED105000 $2 bisacsh
072 7 $a MKL $2 thema
082 0 4 $a 615.78 $2 23
090 $a RM315 $b .B451 2023
100 1 $a Belmaker, Robert Haim. $3 1431834
245 1 0 $a Psychopharmacology reconsidered $h [electronic resource] : $b a concise guide exploring the limits of diagnosis and treatment / $c by Robert Haim Belmaker, Pesach Lichtenberg.
260 $a Cham : $c 2023. $b Springer International Publishing : $b Imprint: Springer,
300 $a xiv, 220 p. : $b ill., digital ; $c 24 cm.
520 $a This thought-provoking book covers the full range of psychopharmacologic practice in textbook fashion, offering a fresh and comprehensive self-examination. Unlike conventional texts of psychopharmacology, this text speaks directly to clinicians who have started to question the limitations of psychopharmacologic claims and the rigid confines of DSM-5 diagnoses. Drawing from their clinical and research experience as well as new literature, the well-published authors provide a new perspective that encourages readers to reevaluate established practices and embrace that medication is just one component of treatment and has limits. The book could be used by psychiatric residents in their course of study, by clinical psychology students taking a psychopharmacology course, or by psychiatrists curious to get a readable but comprehensive look at new critical viewpoints in psychopharmacology that have changed since they were taught. Many neuroscience students who are looking for a review of clinical effects to guide their basic research may also find the proposed text more useful than those texts that collate clinical trials. Current texts are for specialized scientists or are part of multi-authored texts which list drugs alphabetically with no conceptual framework, or books that pretend that each biochemical drug property has a clear and known clinical result presented in cartoon style. Some lesser known texts for psychology or nursing students are not authoritative. Others aimed at patients or families are too simplistic for clinicians. The authors' goal was to create a unified text expressing their view of psychopharmacology, its evidence base, the unity of its essential principles, and its independence of DSM or ICD diagnosis. Several new history books describe the "rise and fall" of psychopharmacology, the corruption of big pharma and the failure of large controlled clinical trials. Psychopharmacology Reconsidered: A Concise Guide Exploring the Limits of Diagnosis and Treatment ensures that young clinicians are aware of and understand this critical zeitgeist but aware also of the essential core of psychopharmacology and the evidence upon which it rests.
650 0 $a Psychopharmacology. $3 644799
650 1 4 $a Psychiatry. $3 585488
650 2 4 $a Neurology. $3 593894
650 2 4 $a Neuropharmacology. $3 677629
650 2 4 $a Neurological Disorders. $3 1388151
650 2 4 $a Diagnosis. $3 654481
650 2 4 $a Therapeutics. $3 644915
700 1 $a Lichtenberg, Pesach. $3 1431835
710 2 $a SpringerLink (Online service) $3 593884
773 0 $t Springer Nature eBook
856 4 0 $u https://doi.org/10.1007/978-3-031-40371-2
950 $a Medicine (SpringerNature-11650)